[1]
“CLINICAL EFFICACY AND SAFETY OF THE COMBINATION OF ROSUVASTATIN AND EZETIMIBE IN THE TREATMENT OF DYSLIPIDEMIA”, EJHSMI, vol. 2, no. 3, pp. 38–41, Mar. 2026, Accessed: Apr. 04, 2026. [Online]. Available: https://eurekaoa.com/index.php/5/article/view/582